Skip to main content

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

ENGN holding history

enGene Therapeutics Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ENGN overviewAll 13F holders of ENGNFull Q2 2026 holdings

Shares (Q2 2026)
829,700
Value
$1.44M
% of portfolio
<0.1%
Quarters held
4
Since Q2 2025
Holdings of ENGN by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026829,700$1.44M<0.1%+673,600+431.5%AddedHolders
Q1 2026156,100$1.06M<0.1%+135,318+651.1%AddedHolders
Q4 202520,782$187.7K<0.1%+20,782NewHolders
Q3 20250$00.0%−11,400−100.0%Sold outHolders
Q2 202511,400$41.5K<0.1%+11,400NewHolders